Description

The Genbody COVID-19 Rapid Antigen Test is a lateral flow immunoassay intended for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 in  nasal pharyngeal swab specimens.

Expiration Date: 11/2025

• CLIA Waived
• Time to results in 15-20 mins
• Collection Method: Anterior Nasal
• For use in the Point-of-Care setting
  
• For use under an Emergency Use Authorization (EUA) Only
• For in vitro diagnostic use only
• Identifies acute infection with a 92.31% sensitivity and 99.04 specificity
• For professional use only
• 25 tests per box

Product Attachments:

• Letter of Authorization
• Instructions for Use
• Quick Reference Instructions
• Sales Flyer